11Nov2020 So You Have a Cool Platform. The Next Decision Will Make or Break Your Company /Alex Harding/2/All, Venture Capital11 Nov 2020 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.